Download video

Dr. Shuch on Caveats of Avelumab/Axitinib Combination in RCC

201 views

OncLive

5 years ago

Dr. Shuch on Caveats of Avelumab/Axitinib Combination in RCC

Dr. Shuch on Caveats of Avelumab/Axitinib Combination in RCC

Dr. Shuch on Caveats of Avelumab\/Axitinib Combination in RCC
1:37
Dr. Shuch on Caveats of Avelumab\/Axitinib Combination in RCC
by OncLive
Dr. Shuch on Considerations for Appropriate Treatment in Advanced RCC
1:59
Dr. Shuch on Considerations for Appropriate Treatment in Advanced RCC
by OncLive
Dr. Choueiri Discusses Avelumab\/Axitinib Data in RCC
1:47
Dr. Choueiri Discusses Avelumab\/Axitinib Data in RCC
by OncLive
Exploring the Combination of First-Line Avelumab\/Axitinib in HCC
3:18
Exploring the Combination of First-Line Avelumab\/Axitinib in HCC
by Targeted Oncology
Dr. Choueiri on Avelumab Plus Axitinib in mRCC
1:38
Dr. Choueiri on Avelumab Plus Axitinib in mRCC
by OncLive
Pembrolizumab\/Axitinib and Avelumab\/Axitinib combo for RCC
1:00
Pembrolizumab\/Axitinib and Avelumab\/Axitinib combo for RCC
by VJOncology
Dr. Shuch on the Impact of the SURTIME Trial in Advanced RCC
2:15
Dr. Shuch on the Impact of the SURTIME Trial in Advanced RCC
by OncLive
Dr. McGregor on the Utility of Axitinib\/Avelumab in Advanced RCC
1:06
Dr. McGregor on the Utility of Axitinib\/Avelumab in Advanced RCC
by OncLive
Avelumab and axitinib for the treatment of advanced RCC
0:57
Avelumab and axitinib for the treatment of advanced RCC
by VJOncology
Final results of avelumab and axitinib in RCC in the JAVELIN Renal 101 trial
1:24
Final results of avelumab and axitinib in RCC in the JAVELIN Renal 101 trial
by VJOncology
Combining avelumab and axitinib in advanced renal cell carcinoma (RCC)
2:27
Combining avelumab and axitinib in advanced renal cell carcinoma (RCC)
by VJOncology
Dr. Shuch on Biology of Non-Clear Cell RCC
1:05
Dr. Shuch on Biology of Non-Clear Cell RCC
by OncLive
Biomarker analysis from JAVELIN Renal 101: Avelumab plus axitinib versus sunitinib in aRCC
3:22
Biomarker analysis from JAVELIN Renal 101: Avelumab plus axitinib versus sunitinib in aRCC
by ecancer
Novel Combinations in mRCC: Axi\/Pembro vs Axi\/Avelumab
10:15
Novel Combinations in mRCC: Axi\/Pembro vs Axi\/Avelumab
by OncLive
Avelumab plus axitinib improves survival in advanced renal-cell carcinoma patients
2:32
Avelumab plus axitinib improves survival in advanced renal-cell carcinoma patients
by infocusrx today
Study on avelumab and axitinib vs sunitinib in the treatment of advanced renal cell carcinoma
9:30
Study on avelumab and axitinib vs sunitinib in the treatment of advanced renal cell carcinoma
by ecancer
Avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
4:39
Avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
by ecancer
Avelumab plus axitinib shows good efficacy for OS and PFS in aRCC patients
0:47
Avelumab plus axitinib shows good efficacy for OS and PFS in aRCC patients
by VJOncology
Genetic Testing for Hereditary Forms of Kidney Cancer - Brian Shuch, MD
1:37
Genetic Testing for Hereditary Forms of Kidney Cancer - Brian Shuch, MD
by UCLA Health
Treating kidney cancer with axitinib \&avelumab, or axitinib \& pembrolizumab?
2:16
Treating kidney cancer with axitinib \&avelumab, or axitinib \& pembrolizumab?
by MedEdOTG